Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groton Biosystems was a life science instrumentation company that specialized in automated sampling and analysis solutions for the biopharmaceutical industry. The company's primary focus was on developing systems that integrated bioreactors with analytical instruments to provide real-time monitoring of cell culture and fermentation processes. Their flagship products, such as the 7100 Multi-channel Bio-reactor Sampling system, enabled researchers to automate the collection and preparation of samples, significantly reducing manual labor and improving data accuracy in process development. Groton Biosystems was eventually acquired by YSI (now part of Xylem), where its technology continues to support bioprocess monitoring and control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Groton Biosystems.